ISCOM technology-based Matrix M (TM) adjuvant: success in future vaccines relies on formulation

Research output: Contribution to journal › Article › Academic › peer-review

151 Citations (Scopus)

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e7a9794d87fc478a97316c78ecaa8382,

title = "ISCOM technology-based Matrix M (TM) adjuvant: success in future vaccines relies on formulation",

author = "KL Bengtsson and B Morein and Ab Osterhaus",

year = "2011",

doi = "10.1586/erv.11.25",

language = "Undefined/Unknown",

volume = "10",

pages = "401--403",

journal = "Expert Review of Vaccines",

issn = "1476-0584",

publisher = "Taylor \& Francis Ltd (UK)",

number = "4",

}

TY - JOUR

T1 - ISCOM technology-based Matrix M (TM) adjuvant: success in future vaccines relies on formulation

AU - Bengtsson, KL

AU - Morein, B

AU - Osterhaus, Ab

PY - 2011

Y1 - 2011

U2 - 10.1586/erv.11.25

DO - 10.1586/erv.11.25

M3 - Article

C2 - 21506635

SN - 1476-0584

VL - 10

SP - 401

EP - 403

JO - Expert Review of Vaccines

JF - Expert Review of Vaccines

IS - 4

ER -